Nalaganje...

Transplantation for Myelodysplastic Syndromes 2013

PURPOSE OF THE REVIEW: The only current treatment capable of curing patients with myelodysplastic syndromes (MDS) is allogeneic hematopoietic stem cell transplant (HCT). However, many MDS patients are older, often with substantial co-morbid conditions, and the disease is heterogeneous. As a conseque...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vaughn, Jennifer E., Scott, Bart L., Deeg, H. Joachim
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3933200/
https://ncbi.nlm.nih.gov/pubmed/24104409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0b013e328364f547
Oznake: Označite
Brez oznak, prvi označite!